Allied Market Research
Loading...
0
Upcoming Allied Market Research
2022
Menstrual Cramps Treatment Market

Menstrual Cramps Treatment Market, by Type (Primary Dysmenorrhea and Secondary Dysmenorrhea), Treatment (Pain Relievers, Hormonal Therapy, and Surgery), Mode of Prescription (Prescription and Over the Counter), Route of Administration (Oral, Parenteral, Implants, and Others), and End User (Hospitals, Ambulatory Surgical Centers, Specialty Centers, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2030

A15451
Pages: NA
Jul 2022 | 126 Views
   
Author(s) : NA
Tables: NA
Charts: NA
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • It comes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Menstrual Cramps Treatment Market

Request Now !

Dysmenorrhea is a clinical term for menstrual cramps, in which females experience severe pains in the lower abdomen that can migrate to the lower legs and the back. A majority of women experience dysmenorrhea during puberty, usually within four to five years of their first menstrual cycle. Prostaglandins are substances that are produced in the uterine lining during menstruation, which generate muscle contractions in the uterus, causing pain and reducing blood and oxygen flow to the uterus. Menstrual problems can be caused by a wide range of underlying diseases. To establish the cause, physicians often rely on the patient's medical history, physical examination, and laboratory tests, which pinpoints the exact reason for menstruation irregularity and allows the doctor to plan an appropriate treatment.

COVID-19 Impact Analysis

Pharmaceutical and biotech companies together with governments are working to address the COVID-19 outbreak globally, from supporting the development of vaccines to planning for medicine supply chain challenges.

Currently, about 115 vaccine samples and 155 molecules are in the R&D pipeline. Furthermore, the implementation of lockdown due to the COVID-19 pandemic has delayed the treatment for menstrual cramps; thereby, having a negative impact on the market. This was attributed to the fact that due to the COVID-19 pandemic many hospitals across the globe were restructured to increase hospital capacity for patients diagnosed with COVID-19. This in turn is expected to have a significant impact on the menstrual cramps treatment market. 

Top Impacting Factors

  • Lifestyle changes, environmental changes, and food choices have a substantial impact on human bodies. This has increased the prevalence of dysmenorrhea among women, which is a significant driver for the global menstrual cramps treatment market.
  • The rise in the prevalence of dysmenorrhea has resulted in an increase in health awareness among women to combat the disorder, which in turn is expected to propel market growth. 
  • Consumers' growing awareness of dysmenorrhea treatment and the low cost of over-the-counter pharmaceuticals are two major reasons to propel growth in the menstrual cramps treatment market.
  • The upsurge in the use of medications to help with pain during the menstrual cycle, in turn, stimulates the global menstrual cramps treatment market growth.
  • Furthermore, the rise in technological advancement in the healthcare industry is expected to drive the growth of the menstrual cramps treatment market during the forecast period.
  • However, side effects and problems of long-term care, the high morbidity of dysmenorrhea leading to insufficient therapy, and traditional family values are anticipated to hinder the expansion of the menstrual cramps treatment market.

Market Trends

New Product Launches to Flourish Menstrual Cramps Treatment Market

In July 2020, Teva Pharmaceuticals USA, Inc., which holds Takeda in 
a joint business venture in the Japanese market, announced a new strategy for its local commercial operations. This strategy has enhanced the company's presence in the Japanese market and propels its revenue growth.

In March 2018, GlaxoSmithKline Plc. declared a successful agreement with Novartis to acquire full ownership of the consumer healthcare business. This agreement helped the company to escalate its product portfolio and revenue growth of the company.

In January 2021, Pfizer, Inc. and Myovant Sciences announced a positive phase 3 spirit extension study of once-daily relugolix combination therapy in women with endometriosis. The therapy reported clinically meaningful reductions in dysmenorrhea. 

In September 2019, Bayer announced data demonstrating a single maximum non-prescription dose of Aleve provided more pain relief over 12 hours than acetaminophen for menstrual cramps due to primary dysmenorrhea.

Key Benefits of Report

  • This study presents the analytical depiction of the menstrual cramps treatment along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the menstrual cramps treatment market share.
  • The current market is quantitatively analyzed from 2020 to 2030 to highlight the menstrual cramps treatment market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market. 
  • The report provides a detailed menstrual cramps treatment market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions Answered in Menstrual Cramps Treatment Market Report

  • Who are the leading market players active in the menstrual cramps treatment market?
  • What current trends will influence the menstrual cramps treatment market in the next few years?
  • What are the driving factors, restraints, and opportunities in the menstrual cramps treatment market?
  • What future projections would help in taking further strategic steps?
  • What is menstrual cramps treatment?
  • What is menstrual cramps treatment market prediction for the future?
  • Who are the leading global players in the menstrual cramps treatment market?
  • What are the current trends and predicted trends?
  • What are the key benefits of the menstrual cramps treatment market report?

Key Market Segments

Segments Sub-segments
By Type
  • Primary Dysmenorrhea
  • Secondary Dysmenorrhea
By Treatment
  • Pain Relievers
  • Hormonal Therapy
  • Surgery
By Mode of Prescription
  • Prescription
  • Over the Counter
By Route of Administration
  • Oral
  • Parenteral
  • Implants
  • Others
By End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Centers
  • Others
By Region
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA


Key Market Players

  • Novartis AG
  • Bayer AG
  • Abbott Laboratories, F
  • Hoffmann-La Roche Ltd.
  • Sanofi
  • Pfizer, Inc.
  • GlaxoSmithKline Plc
  • Focus Consumer Healthcare
  • Johnson & Johnson
  • Alvogen
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
PURCHASE OPTIONS

Start reading ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Call or Email us

U.S.-Canada
Toll-free :
+1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com
 
Allied Market Research Allied Market Research Allied Market Research

Access from any device, anywhere

Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

FREQUENTLY ASKED
QUESTIONS?

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

REQUEST TOC/SAMPLE

OR

Purchase Full Report of
Menstrual Cramps Treatment Market

Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,456
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,769
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $9,995
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Erythropoietin Drugs Market

Global Opportunity Analysis and Industry Forecast, 2021–2028

Published in May 2021

Download Sample

Protein Therapeutics Market

Global Opportunity Analysis and Industry Forecast, 2021–2030

Published in Feb 2022

Download Sample

Surgical Equipment Market

Global Opportunity Analysis and Industry Forecast, 2020-2027

Published in Jan 2021

Download Sample

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020–2027

Published in Nov 2020

Download Sample

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers